VERONICA REZA: Open Payments
NPI 1801027180 · MIDLOTHIAN, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$287 in 16 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $287
Food & beverage: $287
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $74 |
| PFIZER INC. | 4 | $73 |
| Novo Nordisk Inc | 2 | $45 |
| AstraZeneca Pharmaceuticals LP | 2 | $28 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
| Antares Pharma, Inc. | 1 | $15 |
Products named: PREVNAR 20, JARDIANCE, Wegovy, Auvelity, NURTEC ODT, XIFAXAN, Rybelsus, Kerendia.
Industry payments across VA — which companies pay providers there.
